Login

Anders Hinsby, CEO of Orphazyme 00:00:00

Share On Facebook Share On Twitter

Navigating the rare disease space: Insights from Orphazyme's CEO

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Fuller Industrial: Comprehensive Solutions for Cost-Efficient Global Operations
00:10:00
Dolby Laboratories' President and CEO Kevin Yeaman, alongside San Francisco Mayor Edwin Lee, formally inaugurated Dolby's new headquarters.|Dolby Laboratories President and Chief Executive Officer Kevin Yeaman
00:10:00
Polymetals Resources Identifies High-Grade Gold Zones at Mansala Project | Mr. Alex Hanly, CEO , Polymetals Resources Ltd.
00:10:00
The invariant subspace method was applied to the study of continuous-time quantum walk (CTQW)|Chen-Fu Chiang,Quantum technologies
00:10:00
This is such an insightful and transparent discussion about the challenges and transformations your company went through.
00:10:00
CEO Luiz Osório Dumoncel on the Company's Growth and Unique Position in Agribusiness | Luiz Osório Dumoncel, CEO, Três Tentos Agroindustrial SA.
00:10:00
Camino a la excelencia translates to "Pathway to excellence."
00:10:00
Maximizing Cannabis Cultivation: Insights from Chris O'Farrell's Expert Guide
00:10:00
The Politics of Tribal Nonsense: Exploring Wokeness and Marxist Ideologies|Wilfred Reilly,Professor,Kentucky State University
00:10:00
Paolo Gamberoni Talks Innovation and Leadership at Creactives Group | Paolo Gamberoni, CEO , Creactives Group S P A.
00:10:00
Webinar: New 2023 Colorado Employer Mandates - Secure Savings & Paid Sick Leave | Eric Walters - Managing Partner, Founder of Summit Hill Wealth Management
00:10:00
The Evolving FinTech Landscape|Andrew Steele,Partner,Activant Capital

© 2026 Nehu